Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

7.80
Delayed Data
As of 10:10am ET
 +0.10 / +1.30%
Today’s Change
6.17
Today|||52-Week Range
22.66
-37.05%
Year-to-Date

Today’s Trading

Previous close7.70
Today’s open7.66
Day’s range7.66 - 7.93
Volume11,755
Average volume (3 months)153,845
Market cap$267.7M
Dividend yield--
Data as of 10:10am ET, 05/06/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)-13.24%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...-0.29-4.43%
ADXSAdvaxis Inc-0.09-1.18%
PTCTPTC Therapeutics Inc+0.37+5.38%
CMRXChimerix Inc-0.01-0.19%
Data as of 10:25am ET, 05/06/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs